Selectieve oestrogeenreceptormodulator (Dutch Wikipedia)

Analysis of information sources in references of the Wikipedia article "Selectieve oestrogeenreceptormodulator" in Dutch language version.

refsWebsite

Global rank Dutch rank

6nih.gov

4^th place

12^th place

6doi.org

2^nd place

8^th place

1ama-assn.org

3,257^th place

1,970^th place

ama-assn.org

jama.ama-assn.org

Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators (July 2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 (3): 321–33. PMID 12117397. DOI: 10.1001/jama.288.3.321.

doi.org

Riggs BL, Hartmann LC (2003). Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice. N Engl J Med 348 (7): 618–29. PMID 12584371. DOI: 10.1056/NEJMc030651.
Somjen D, Katzburg S, Knoll E, Hendel D, Stern N, Kaye AM, Yoles I (May 2007). DT56a (Femarelle): a natural selective estrogen receptor modulator (SERM). J. Steroid Biochem. Mol. Biol. 104 (3-5): 252–8. PMID 17428655. DOI: 10.1016/j.jsbmb.2007.03.004.
Reeves GK, Beral V, Green J, Gathani T, Bull D (November 2006). Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol. 7 (11): 910–8. PMID 17081916. DOI: 10.1016/S1470-2045(06)70911-1.
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators (July 2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 (3): 321–33. PMID 12117397. DOI: 10.1001/jama.288.3.321.
Shang Y, Brown M (2002). Molecular determinants for the tissue specificity of SERMs. Science 295 (5564): 2465–8. PMID 11923541. DOI: 10.1126/science.1068537.
Smith CL, O'Malley BW (2004). Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 25 (1): 45–71. PMID 14769827. DOI: 10.1210/er.2003-0023.

nih.gov

ncbi.nlm.nih.gov

Riggs BL, Hartmann LC (2003). Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice. N Engl J Med 348 (7): 618–29. PMID 12584371. DOI: 10.1056/NEJMc030651.
Somjen D, Katzburg S, Knoll E, Hendel D, Stern N, Kaye AM, Yoles I (May 2007). DT56a (Femarelle): a natural selective estrogen receptor modulator (SERM). J. Steroid Biochem. Mol. Biol. 104 (3-5): 252–8. PMID 17428655. DOI: 10.1016/j.jsbmb.2007.03.004.
Reeves GK, Beral V, Green J, Gathani T, Bull D (November 2006). Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol. 7 (11): 910–8. PMID 17081916. DOI: 10.1016/S1470-2045(06)70911-1.
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators (July 2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 (3): 321–33. PMID 12117397. DOI: 10.1001/jama.288.3.321.
Shang Y, Brown M (2002). Molecular determinants for the tissue specificity of SERMs. Science 295 (5564): 2465–8. PMID 11923541. DOI: 10.1126/science.1068537.
Smith CL, O'Malley BW (2004). Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 25 (1): 45–71. PMID 14769827. DOI: 10.1210/er.2003-0023.